The impact of an NF1 diagnosis reaches the whole family - having a child with NF1 is associated with long-term declines in parental income and employment growth, highlighting the need for tailored support for families. bit.ly/4yUkca3
How often should BRCA1/2 genomic variants be reinterpreted? Modeling suggests periodic, time-limited reclassification is more cost-effective than indefinite review, with much of the benefit extending to relatives through cascade testing. bit.ly/48tgvgx
P-KNN is a new variant classification tool that integrates multiple pathogenicity prediction models into a single, calibrated score, rather than precommitment to a single predictor, providing stronger evidence of pathogenicity. bit.ly/4e4zkdm
Can PRS truly personalize cancer screening? Patients and clinicians were more likely to intensify screening after high-risk PRS results than reduce screening after low-risk results, highlighting challenges in risk communication. bit.ly/48gJu7c
A new online tool for hereditary cancer patients helped more people share genetic test results but didn’t increase follow-up talks. Clinician support in family communication as test results are first shared may increase distribution of information bit.ly/3W2iS7i
An EHR-based score to flag people likely to have severe AATD (PiZZ) using routine data like COPD, bronchiectasis, cirrhosis, and height; could cut testing by 95%+ vs random screening. bit.ly/4yIlCnX
Pharmacogenomic (PGx)-guided therapy can reduce preventable adverse drug reactions. Most individuals carry at least one actionable #PGx#phenotype, and nearly half in this study had an #ADR-risk phenotype linked to a prescribed medication. bit.ly/4i1Q4D2
Negative blood exome sequencing does not exclude mosaic disease. This CGC review highlights affected-tissue sampling, high-depth NGS, ddPCR, and low-VAF variant interpretation in somatic overgrowth and vascular anomalies. bit.ly/47A99Ym
Biallelic SEPSECS variants cause a spectrum from severe neonatal encephalopathy to childhood-onset ataxia and cognitive decline. Pontine involvement is uncommon, supporting shift from “PCH2D” to SEPSECS-related NDD bit.ly/47jVzZ3
Rapid genome sequencing (RGS) identified actionable genetic conditions in nearly 40% of non-ICU care individuals, with majority having medical management changes within 30 days, highlighting utility of RGS outside of critical care settings. bit.ly/4hziTba